Description

Senior communications leader with 7+ years' experience advising global pharmaceutical and healthcare organisations within top-tier agencies. Trusted at senior client level to develop corporate narratives, lead complex multi-market programmes, and deliver advocacy-aligned communications in highly regulated and high-scrutiny environments. Known for clear thinking, strong structure, and calm leadership, with a track record of aligning senior stakeholders, stabilising challenged accounts, and delivering measurable impact across corporate, brand, and patient-led programmes.

Industry field of expertise

Languages

English
Native or bilingual

Workplace preferences

Can work on-site

London (up to 10km)

Burson Global
Senior Account Director
PHARMACEUTICALS INDUSTRY
May 2024 - Today (2 years and 1 month)
London, United Kingdom
Provided senior strategic counsel and cross-functional leadership across global healthcare accounts, leading complex programmes from brief to delivery.

Designed and co-facilitated a senior stakeholder reputation risk workshop for a global workstream launch, grounding the session in media narrative analysis and a likelihood-impact scoring framework; produced a prioritised risk register and first-step comms actions ahead of external visibility
Acted as day-to-day strategic lead on a global communications programme spanning the US and key EU markets, owning senior client relationships and convening cross-functional teams across comms, data and insights, digital, and studio
Stabilised a challenged global account by resetting programme structure, team alignment, and ways of working, restoring client confidence and delivery momentum
Designed and implemented a bespoke media monitoring and analysis framework, tracking sentiment, share of voice, and competitive positioning - adopted beyond its initial brand scope by other teams within the organisation
Helped to delivered 55% share of voice against two direct competitors entering the market, contributing to sustained brand awareness
Led planning and execution of an exclusive international media activation at a US manufacturing facility, coordinating global comms, in-market media teams, and production partners; travelled to the US to lead on the ground and deliver high-impact coverage and reusable content assets for global markets
Owned financial oversight across c. £1.5m in programmes, ensuring delivery against scope while maintaining programme profitability
Built and mentored account teams, supporting progression and providing ongoing leadership across multiple workstreams
Communication strategy Corporate communications
Portland Communications
Consultant - Senior Consultant (Account Director)
PRESS AND MEDIA
April 2021 - May 2024 (3 years and 1 month)
London, United Kingdom
Delivered strategic advisory and stakeholder engagement across rare and specialist disease areas, with a focus on corporate narrative, executive alignment, and advocacy-led communications.
Led development of a new UK corporate narrative for a major pharmaceutical client navigating a significant post-pandemic reputation shift, working directly with the UK CEO and Director of Communications; co- facilitated an internal messaging workshop alongside the agency Chair and worked with the public affairs team to ensure resonance across media and policy audiences
Delivered a full suite of outputs including a messaging framework, corporate narrative document, Q&A, and external comms activation recommendations - used to inform national media activity including a broadsheet profile with the UK President
Designed and facilitated executive workshops to align leadership messaging, strengthen corporate narratives, and build crisis preparedness ahead of high-stakes announcements
Supported crisis preparedness planning for a high-profile regulatory reappraisal, facilitating scenario planning and developing response frameworks in a sensitive and highly scrutinised environment
Led strategy and creative development for an adolescent-focused workstream within a European rare disease advocacy campaign, managing co-creation directly with young patients and directing campaign identity and launch; soft launch reached 3.7 million people (44% target audience); phase two reached 5.1 million with 80%+ target audience penetration and a 1,200% increase in engagement
Oversaw delivery of a multi-market European advocacy campaign, supporting expansion from eight to over twenty countries and strengthening patient community engagement in policy and awareness activity
Directed campaign presence at a major European patient congress, overseeing booth design, content capture, and stakeholder engagement; supported distribution of a position paper
Corporate communications Communication strategy Narrative and Brand Patient Advocacy Workshop Facilitation
FTI Consulting
Graduate - Consultant - Senior Consultant (AE-SAM)
HEALTH AND WELLNESS
September 2018 - April 2021 (2 years and 7 months)
London, United Kingdom
Built cross-disciplinary foundations across financial communications, public affairs, and corporate communications within the life sciences sector.

Supported regulatory approval communications for a global pharmaceutical client, developing stakeholder materials and contributing to crisis preparedness in a complex political and media environment
Led delivery of a patient-led disease awareness campaign for a medical technology innovation, producing compliant campaign materials, conference support, and digital content
Gained grounding in financial communications and investor relations, building commercial understanding that continues to inform corporate narrative and stakeholder engagement work
Corporate communications Communication strategy Narrative and Brand